Crown Advisors Management, Inc. Axonics, Inc. Transaction History

Crown Advisors Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$52.6 - $67.34 $263,000 - $336,700	5,000 Added 50.0%	15,000 $818,000
Q2 2022 Aug 11, 2022	BUY	$39.5 - $64.42 $395,000 - $644,200	10,000 New	10,000 $566,000
Q1 2020 May 05, 2020	SELL	$16.44 - $37.73 $1.64 Million - $3.77 Million	-100,000 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$19.57 - $28.96 $1.96 Million - $2.9 Million	100,000 New	100,000 $2.77 Million

5.03M

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Crown Advisors Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Crown Advisors Management, Inc. with notifications on news.